- DavidsTea Inc (NASDAQ:DTEA) has expanded its agreement with Loblaw Companies Limited (OTC:LBLCF) to extend its product offerings across the Atlantic provinces, Ontario, Manitoba, Saskatchewan, Alberta, and British Columbia.
- “DAVIDsTEA is excited to further strengthen its relationship with Canada’s food and pharmacy leader, allowing us to offer our customers access to an even broader selection of our high-quality teas,” said CEO Sarah Segal.
- DavidsTea noted select products are available in over 1,250 Loblaw grocery and pharmacy storefronts across Canada.
- DavidsTea has added an assortment of flavors in loose-leaf tins and fruity matcha single-serves to Loblaw’s existing assortment of sachet product selection.
- Price Action: DTEA shares are trading higher by 1.61% at $3.465 on the last check Tuesday.
REGENXBIO Presents Initial Data from Phase II AAVIATE® Trial of RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery and Provides Trial Update at Retina Society 54th Annual Scientific Meeting
Suprachoroidal delivery of RGX-314 well tolerated in 50 patients in Cohorts 1-3 with no drug-related serious adverse events
Positive initial data from Cohort 1 at six months after one-time treatment of
